Scarica l'app Stockscreener
2.01
0.50%
-0.01
Dopo l'orario di chiusura:
2.03
0.02
+1.00%
Precedente Chiudi:
$2.02
Aprire:
$2.05
Volume 24 ore:
15.86M
Relative Volume:
3.32
Capitalizzazione di mercato:
$186.38M
Reddito:
-
Utile/perdita netta:
$-69.31M
Rapporto P/E:
-1.5827
EPS:
-1.27
Flusso di cassa netto:
$-62.80M
1 W Prestazione:
-81.63%
1M Prestazione:
-80.33%
6M Prestazione:
-51.33%
1 anno Prestazione:
-54.73%
Intervallo 1D:
$1.84
$2.25
Intervallo di 1 settimana:
$1.07
$2.25
Portata 52W:
$1.07
$11.46
Rezolute Inc Stock (RZLT) Company Profile
Nome
Rezolute Inc
Settore
Industria
Telefono
650-206-4507
Indirizzo
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Confronta RZLT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
2.01 | 187.31M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-12-11 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-12-11 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-11-05 | Iniziato | Wedbush | Outperform |
| 2024-08-27 | Iniziato | Guggenheim | Buy |
| 2024-07-17 | Iniziato | BTIG Research | Buy |
| 2024-06-04 | Iniziato | Craig Hallum | Buy |
| 2024-04-09 | Iniziato | Maxim Group | Buy |
| 2022-08-02 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-09-08 | Iniziato | ROTH Capital | Buy |
| 2021-05-27 | Iniziato | Oppenheimer | Outperform |
| 2021-05-25 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Rezolute Inc Borsa (RZLT) Ultime notizie
Top Executive Makes Bold Move in Rezolute Stock! - TipRanks
Insider Buying: Wladimir Hogenhuis Acquires Additional Shares of Rezolute Inc (RZLT) - GuruFocus
RZLT: Rezolute, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm - GlobeNewswire
RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know - Finviz
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - PR Newswire
Elam Nevan C, Rezolute CEO, buys $50k in RZLT shares - Investing.com Nigeria
Rezolute, Inc. (RZLT) Under Investigation for Potential Securities Law ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - GlobeNewswire Inc.
Elam Nevan C, Rezolute CEO, buys $50k in RZLT shares By Investing.com - Investing.com South Africa
Entry Recap: Will Rezolute Inc stock outperform value stocksInflation Watch & AI Enhanced Trading Signals - moha.gov.vn
Rezolute CFO Evans buys shares worth $79,577 By Investing.com - Investing.com Canada
Rezolute (NASDAQ:RZLT) CEO Purchases $50,880.00 in Stock - MarketBeat
Rezolute (NASDAQ:RZLT) Insider Purchases 12,100 Shares - MarketBeat
Nevan Elam Increases Stake in Rezolute Inc with Recent Share Pur - GuruFocus
Rezolute’s CCO Karnawat buys $19,598 in shares By Investing.com - Investing.com Australia
Rezolute’s CCO Karnawat buys $19,598 in shares - Investing.com India
RZLT ALERT: Levi & Korsinsky Investigates Rezolute, Inc. on Behalf of Shareholders Who Lost Money - ACCESS Newswire
Rezolute CFO Evans buys shares worth $79,577 - Investing.com
CFO Evans Buys 45,000 ($79.6K) Of Rezolute Inc [RZLT] - TradingView — Track All Markets
Rezolute Inc. trading resumes - MSN
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure — Hagens Berman Investigating RZLT Investors with Losses Encouraged to Contact the Firm - Morningstar
Rezolute Inc trading halted, volatility trading pause - MSN
Down 81.8% in 4 Weeks, Here's Why Rezolute (RZLT) Looks Ripe for a Turnaround - Finviz
Rezolute downgraded to neutral from outperform at Wedbush - MSN
Rezolute (RZLT): Reassessing Valuation After sunRIZE Phase 3 Failure and Growing Legal Scrutiny - simplywall.st
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - TMX Newsfile
Rezolute price target raised to $20 from $15 at Jefferies - MSN
H.C. Wainwright Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛
HC Wainwright Decreases Earnings Estimates for Rezolute - MarketBeat
Rezolute (RZLT) Is Down 82.7% After Phase 3 sunRIZE Failure in Congenital Hyperinsulinism Trial - Yahoo Finance
Rezolute shares collapse after phase 3 trial fails to meet main goals - MSN
Rezolute (NASDAQ:RZLT) Downgraded by Citizens Jmp to Hold - MarketBeat
Rezolute’s phase 3 study in congenital hyperinsulinism did not meet endpoints - MSN
Rezolute price target lowered to $5 from $14 at HC Wainwright - MSN
Investors Buy Large Volume of Rezolute Call Options (NASDAQ:RZLT) - MarketBeat
Guggenheim Issues Pessimistic Forecast for Rezolute (NASDAQ:RZLT) Stock Price - MarketBeat
Jefferies Raises Rezolute Price Target Amid Favorable Data Prospects - timothysykes.com
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - TMX Newsfile
Wedbush downgrades Rezolute to neutral after congenital hyperinsulinism miss - MSN
Rezolute plunges as lead asset fails in late-stage trial - MSN
Guggenheim maintains Rezolute (RZLT) buy recommendation - MSN
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial FailureHagens Berman Investigating - The Malaysian Reserve
Rezolute (NASDAQ:RZLT) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Rezolute stock crashes after sole pipeline candidate fails Phase III - MSN
Rezolute (NASDAQ:RZLT) Reaches New 12-Month Low on Analyst Downgrade - MarketBeat
Guggenheim Maintains Rezolute (RZLT) Buy Recommendation - Nasdaq
Jefferies Raises Rezolute’s Price Target Amid Promising Drug Prospects - StocksToTrade
Is Rezolute Inc. (RZLT) One of the Top Long-Term Biotechnology Stocks to Buy - MSN
RZLT INVESTIGATION: Rezolute, Inc. Investors Should Contact Block & Leviton LLP To Potentially Recover Losses - TradingView — Track All Markets
Rezolute price target lowered to $4 from $20 at Maxim - MSN
Rezolute stock price target slashed by H.C. Wainwright after failed study - Investing.com Nigeria
Rezolute Inc Azioni (RZLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.18%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):